J9130 Dacarbazine 100 milligrams injection
Also known as: dacarbazine, DTIC
Intravenous injection of dacarbazine, an alkylating agent chemotherapy, dosed at 100 milligrams.
In Plain Language
DNA-damaging cancer drug; melanoma treatment
Clinical Context
Used for melanoma and Hodgkin lymphoma. Alkylating agent that requires hepatic activation.
RVU Information
CPT J9130 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9130?
CPT J9130 (Dacarbazine 100 milligrams injection) is a J Codes (Drugs) code. Intravenous injection of dacarbazine, an alkylating agent chemotherapy, dosed at 100 milligrams.
How is J9130 administered?
CPT J9130 is administered by a healthcare provider, typically via injection or infusion. Used for melanoma and Hodgkin lymphoma. Alkylating agent that requires hepatic activation. It is used by Oncology, Medical Oncology.
When is CPT J9130 used?
Used for melanoma and Hodgkin lymphoma. Alkylating agent that requires hepatic activation.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.